Syncona announces Novartis discontinuing development of GT005 for geographic atrophy
Novartis acquired Gyroscope Holdings Limited from Syncona in February 2022.
Orbis and Heidelberg Engineering announce new partnership
The non-profit will partner with the imaging company to prevent blindness and fund new retinoblastoma research.
Sandoz releases positive results from MYLIGHT Phase III study for biosimilar to aflibercept
The study met its primary efficacy endpoint for the neovascular age-related macular degeneration (nAMD) treatment.
Tenpoint Therapeutics launches with $70 million in funding for cell therapy platform
The London-based company will use regenerative medicine to fight ocular disease.
Elios Vision completes enrollment for pivotal US clinical trial
The company seeks to replicate European success of the ELIOS procedure in the US market.
2 Clarke Drive Cranbury, NJ 08512